Prostatic Neoplasms: all 6,484 studies

Page 15 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.

• MR-Guided Cryoablation of Prostate Bed RecurrencesEnrolling by invitationNCT01727284Not applicable
• Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate CancerRecruitingNCT01492972Phase 3
• Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic AnalysisRecruitingNCT01441089
• Epidemiologic and Genetic Study on Familial Prostate CancerRecruitingNCT01221168
• Focal Therapy for Prostate Cancer Using HIFURecruitingNCT01194648Not applicable
• Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerRecruitingNCT01050504
• Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical ProstatectomyRecruitingNCT00969111Not applicable
• Active Surveillance for Cancer of the Prostate (ASCaP)RecruitingNCT00949819
• Collection of Blood From Patients With Prostate CancerRecruitingNCT00923221
• High-Dose-Rate BrachytherapyRecruitingNCT00913939Not applicable
• Prostate Active Surveillance StudyRecruitingNCT00756665
• [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland CancerRecruitingNCT00588185Not applicable
• Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruitingNCT00451022
• Use of Tracking Devices to Locate Abnormalities During Invasive ProceduresEnrolling by invitationNCT00102544Not applicable
• Collection of Blood From Patients With CancerRecruitingNCT00034216
• A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerTerminatedNCT06630325Phase 2Results posted
• Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical ProstatectomyCompletedNCT06604442Phase 4Results posted
• Description of Relugolix Use in Patients With Prostate Cancer Within the VHACompletedNCT06462014Results posted
• DeADT - Living Well With Prostate CancerCompletedNCT06199986Not applicableResults posted
• A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed ForcesCompletedNCT06151418Results posted
• Prostate Resection After Microwave Ablation (PRAMA)CompletedNCT06128525Not applicableResults posted
• A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)CompletedNCT06072196Results posted
• Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF TrialCompletedNCT06016725Not applicableResults posted
• Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP StudyTerminatedNCT05960578Phase 2Results posted
• A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.TerminatedNCT05917470Phase 1/2Results posted
• Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and PainCompletedNCT05803096Phase 4Results posted
• Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate CancerActive, not recruitingNCT05779943Phase 2Results posted
• Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot StudyCompletedNCT05764005Not applicableResults posted
• An Observational Study of Radiotherapy After Injection of SpaceOAR HydrogelCompletedNCT05735652Results posted
• Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate CancerCompletedNCT05730712Phase 2Results posted
• Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandCompletedNCT05701007Results posted
• Contributions to Hypertension With Androgen Deprivation TherapyTerminatedNCT05700903Phase 4Results posted
• Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)Active, not recruitingNCT05696444Not applicableResults posted
• Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical ProstatectomyActive, not recruitingNCT05678322Phase 3Results posted
• Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate CancerCompletedNCT05653856Phase 2Results posted
• Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate CancerActive, not recruitingNCT05628363Not applicableResults posted
• Neo-DAB: Darolutamide and Abemaciclib in Prostate CancerTerminatedNCT05617885Phase 1Results posted
• Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate CancerTerminatedNCT05617040Phase 1/2Results posted
• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateCompletedNCT05605964Phase 3Results posted
• Wrist Cooling for Hot Flashes Clinical TrialCompletedNCT05595213Not applicableResults posted
• Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the ProstateCompletedNCT05590793Phase 3Results posted
• 68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate CancerCompletedNCT05547386Phase 3Results posted
• Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)CompletedNCT05520138Results posted
• Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate CancerTerminatedNCT05501548Phase 2Results posted
• RefleXion PET/CT Imaging Performance in Patients With Prostate CancerActive, not recruitingNCT05470699Not applicableResults posted
• Improving Germline Testing in At-Risk Patients With Prostate CancerCompletedNCT05470036Not applicableResults posted
• Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the ProstateCompletedNCT05458856Phase 3Results posted
• AGN-Cogni.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer PatientsCompletedNCT05375539Phase 1Results posted
• Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of CareTerminatedNCT05366842Phase 2Results posted
• Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically AdministeredCompletedNCT05332340Phase 1Results posted
• RElugolix VErsus LeUprolide Cardiac TrialActive, not recruitingNCT05320406Phase 2Results posted
• A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)Active, not recruitingNCT05288166Phase 3Results posted
• 64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)CompletedNCT05249127Phase 1/2Results posted
• Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)Active, not recruitingNCT05241860Phase 2Results posted
• Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRICompletedNCT05220501Not applicableResults posted
• 68Ga-PSMA-11 PET in Patients With Prostate CancerCompletedNCT05197257Phase 3Results posted
• FIRMAGON® Intensive Drug MonitoringCompletedNCT05181800Results posted
• Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate CancerTerminatedNCT05177770Phase 2Results posted
• Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate CancerCompletedNCT05177042Phase 1Results posted
• A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerTerminatedNCT05169684Phase 2Results posted
• Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
• IGF Inhibition With Xentuzumab Prior to Radical ProstatectomyCompletedNCT05110495Early Phase 1Results posted
• Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate CancerActive, not recruitingNCT05081193Phase 2Results posted
• A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.CompletedNCT05059236Phase 2Results posted
• Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound ImagingCompletedNCT04981223Not applicableResults posted
• Pivotal Study of the NanoKnife System for the Ablation of Prostate TissueCompletedNCT04972097Not applicableResults posted
• A Study of NOX66 and External Beam Radiotherapy in Patients With Metastatic Castration-resistant Prostate Cancer and Other Solid TumorsTerminatedNCT04957290Phase 1/2Results posted
• Olaparib for the Treatment of Castration Resistant Prostate AdenocarcinomaTerminatedNCT04951492Phase 2Results posted
• The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate CancerCompletedNCT04936334Phase 2Results posted
• 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor ExpressionTerminatedNCT04927663Phase 1Results posted
• Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate CancerTerminatedNCT04926181Phase 2Results posted
• Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China ExtensionTerminatedNCT04907227Phase 3Results posted
• HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of GenomicsActive, not recruitingNCT04905082Not applicableResults posted
• Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for TreatmentCompletedNCT04890314Results posted
• TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate CancerCompletedNCT04887506Phase 3Results posted
• Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors DetectionCompletedNCT04838626Phase 2/3Results posted
• Study of Diagnostic Performance of [18F]CTT1057 in BCRCompletedNCT04838613Phase 3Results posted
• Lighting Intervention for Cancer-related FatigueCompletedNCT04827446Not applicableResults posted
• PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2CompletedNCT04815876Not applicableResults posted
• KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural PracticeCompletedNCT04763824Not applicableResults posted
• Abemaciclib With or Without Atezolizumab for mCRPCCompletedNCT04751929Phase 2Results posted
• A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate CarcinomaTerminatedNCT04740034Phase 1Results posted
• Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate CancerTerminatedNCT04737109Phase 1/2Results posted
• Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate CancerCompletedNCT04736199Phase 3Results posted
• Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate CancerCompletedNCT04731844Phase 2Results posted
• 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate CancerTerminatedNCT04727736Phase 2Results posted
• 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate CancerTerminatedNCT04716725Phase 2Results posted
• Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance ImagingTerminatedNCT04698564Phase 2Results posted
• 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate CancerActive, not recruitingNCT04689828Phase 3Results posted
• Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentActive, not recruitingNCT04647526Phase 3Results posted
• Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate CancerTerminatedNCT04635059Phase 2Results posted
• Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)TerminatedNCT04631744Phase 2Results posted
• Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among VeteransCompletedNCT04621500Phase 2Results posted
• Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to BonesTerminatedNCT04616547Phase 2Results posted
• 68 Ga-PSMA for High Risk Prostate CancerCompletedNCT04614363Phase 1/2Results posted
• ARFI Imaging for Targeted Prostate BiopsyTerminatedNCT04607135Not applicableResults posted
• A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image QualityCompletedNCT04565457Not applicableResults posted
• PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)TerminatedNCT04556617Phase 1/2Results posted
• Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate GlandCompletedNCT04530552Phase 2Results posted
• A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for MetastasesCompletedNCT04523207Phase 2Results posted

← Prostatic Neoplasms overview